Biofil Chemicals and Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
For the six months, sales was INR 198.01 million compared to INR 149.25 million a year ago. Revenue was INR 198.57 million compared to INR 149.66 million a year ago. Net income was INR 3.67 million compared to INR 2.52 million a year ago. Basic earnings per share from continuing operations was INR 0.23 compared to INR 0.15 a year ago. Diluted earnings per share from continuing operations was INR 0.23 compared to INR 0.15 a year ago.